Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
6 ½ X 9 7/16 in 1. Overview (Satinder Ahuja).
HPLC Theory (Y.V. K azakevich).
HPLC Columns and Packings (U.D. Neue < EM>et al.).
Column Characterization and Select ion (D. Visky).
Chiral Separations (Xiande Wang et al.).
Contemporary Liquid Chromatographic Systems for Method Development (M. Swartz).
Hyphen ated Techniques (D.L. Norwood et al.).
HP LC Sample Preparation (G. Slack, N.H. Snow).
Instru ment and Software Qualification and Validation (D. Van Geel).
Pharmaceutical Development: From Pre-clinical to Post Appro val (K. Bynum).
HPLC Method Development for Drug D iscovery LC-MS Assays in Rapid PK Applications (Xiaoying Xu, W. Korfmach er).
HPLC Method Development in Early Phase Pharmac eutical Development (H.T. Rasmussen et al.).
1 3. HPLC Method Development in Late Phase Pharmaceutical Development (M. Ilias Jimidar).
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
6 ½ X 9 7/16 in 1. Overview (Satinder Ahuja).
HPLC Theory (Y.V. K azakevich).
HPLC Columns and Packings (U.D. Neue < EM>et al.).
Column Characterization and Select ion (D. Visky).
Chiral Separations (Xiande Wang et al.).
Contemporary Liquid Chromatographic Systems for Method Development (M. Swartz).
Hyphen ated Techniques (D.L. Norwood et al.).
HP LC Sample Preparation (G. Slack, N.H. Snow).
Instru ment and Software Qualification and Validation (D. Van Geel).
Pharmaceutical Development: From Pre-clinical to Post Appro val (K. Bynum).
HPLC Method Development for Drug D iscovery LC-MS Assays in Rapid PK Applications (Xiaoying Xu, W. Korfmach er).
HPLC Method Development in Early Phase Pharmac eutical Development (H.T. Rasmussen et al.).
1 3. HPLC Method Development in Late Phase Pharmaceutical Development (M. Ilias Jimidar).